|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current asset | |||||
| Cash | |||||
| Total current asset | |||||
| Non-current assets | |||||
| Cash held in Trust Account | |||||
| Deferred offering costs | |||||
| Total non-current assets | |||||
| Total Assets | |||||
| Liabilities and Shareholders’ (Deficit)/Equity | |||||
| Current liabilities | |||||
| Promissory note - related party | |||||
| Payable to a third party | |||||
| Total current liabilities | |||||
| Total Liabilities | |||||
| Ordinary shares subject to redemption, 5,750,000 shares (at redemption price of $9.50 per share) | |||||
| Shareholders’ (deficit)/equity | |||||
| Ordinary shares, value | |||||
| Additional paid-in capital | |||||
| (Accumulated deficit)/Retained earnings | |||||
| Total shareholders’ (deficit)/equity | |||||
| Total Liabilities and Shareholders’ (Deficit)/Equity |
Loading...